BaP: Single Arm Phase II trial assessing the safety, compliance and activity, of Bezafibrate and medroxyProgesterone acetate (BaP) as non-toxic therapy against myeloid and lymphoid cancers

Project: Research

Participants

Short titleBaP: Single Arm Phase II trial assessing the safety, compliance and activity, of Bezafibrate and medroxyProgesterone acetate (BaP) as non-toxic therapy against myeloid and lymphoid cancers
StatusFinished
Effective start/end date12/04/1231/12/15